Vascepa OverviewEthyl eicosapentaenoic acid (E-EPA, icosapent ethyl) is a derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA) that is used in combination with changes in diet to lower triglyceride levels in adults with severe (≥ 500mg/dL) hypertriglyceridemia. This was the second class of fish oil-based drug to be approved for use as a drug and was approved by the FDA in 2012. These fish oil drugs are similar to fish oil dietary supplements but the ingredients are better controlled and h...
Read more Vascepa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid
Recent Vascepa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 1g, 1gm, 500mg
NDC Database Records for Vascepa: (3 results)Sorted by National Drug Code
- 52937-001 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.
- 52937-003 Vascepa 500 mg Oral Capsule by Amarin Pharma Inc.
- 52937-101 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.